Effects of polymorphisms of the sex hormone-binding globulin (SHBG) gene on free estradiol and bone mineral density.
BACKGROUND
Polymorphisms of the sex hormone-binding globulin (SHBG) gene are associated with differences in SHBG levels, influencing the risk for breast cancer and polycystic ovarian syndrome, but no association has been reported for osteoporosis in postmenopausal women.


OBJECTIVE
To determine the effect of G to A substitution in the 5'UTR (rs1799941) and the Asp356Asn (rs6259) polymorphisms of the SHBG gene on bone mineral density (BMD).


METHODS
This is a cross-sectional study in a university-based research center from May, 2002 to December, 2007. A total of two hundred and thirteen healthy postmenopausal Caucasian women > or = 1 year from last menstrual period participated to this study. Serum estradiol by ultrasensitive radioimmnunoassay, serum sex hormone-binding globulin by immunoradiometric assay, and urinary NTx by enzyme-linked immunoassay were measured. BMD measurements were performed by dual energy X-ray absorptiometry and genotyping by Pyrosequencing.


RESULTS
There were no significant differences in SHBG levels associated with either rs1799941 or rs6259. Using a p value of <0.00625 for significance, we found that subjects with the A allele (GA+AA) for the rs1799941, had a trend for lower free estradiol index (FEI) compared to the GG genotype (p=0.04). They also had significantly lower BMD at the intertrochanter (p=0.003) and trend for lower BMD at the total hip (p=0.02). There was no significant difference in FEI levels between the genotypes for the rs6259 polymorphism, but women with the Asn allele (Asp/Asn+Asn/Asn), had significantly lower BMD in the total femur (p=0.004) and intertrochanter (0.002) compared to those with the Asp/Asp genotype.


CONCLUSIONS
Our data suggest that polymorphisms of the SHBG gene are associated with significant differences in BMD at the proximal femur sites. Thus, genetic variations in the SHBG gene may influence BMD at the hip in postmenopausal women.
Napoli
Nicola
N
Division of Bone and Mineral Diseases at Washington University School of Medicine, Campus Box 8301, 660 South Euclid Ave. St. Louis, MO 63110, USA.
Varadharajan
Ana
A
Rini
Giovam Batista
GB
Del Fiacco
Romano
R
Yarramaneni
Jayasree
J
Mumm
Steven
S
Villareal
Dennis T
DT
Armamento-Villareal
Reina
R
D020121:5' Untranslated Regions / Q000235:genetics; D015519:Bone Density / Q000235:genetics*; D004958:Estradiol / Q000097:blood*; D005260:Female; D005838:Genotype; D006801:Humans; D008875:Middle Aged; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D012738:Sex Hormone-Binding Globulin / Q000235:genetics*
D020121:5' Untranslated Regions; D012738:Sex Hormone-Binding Globulin; D004958:Estradiol
Endocr Rev. 1990 Feb;11(1):80-91
2180689
J Clin Endocrinol Metab. 2006 Dec;91(12):5029-37
16926255
J Clin Invest. 1992 Dec;90(6):2464-71
1469098
J Clin Endocrinol Metab. 2003 Dec;88(12):5976-80
14671199
J Clin Endocrinol Metab. 2002 Apr;87(4):1443-50
11932262
Menopause. 2004 Mar-Apr;11(2):159-66
15021445
Int J Obes. 1991 Jul;15(7):471-8
1894424
J Natl Cancer Inst. 1995 Feb 1;87(3):190-7
7707406
N Engl J Med. 1998 Sep 10;339(11):733-8
9731089
J Clin Endocrinol Metab. 2006 Dec;91(12):4764-6
17148570
Trends Endocrinol Metab. 1995 Nov-Dec;6(9-10):298-304
18406714
BMC Med Genet. 2008 Dec 17;9:112
19091090
J Natl Cancer Inst. 1996 Mar 6;88(5):291-6
8614008
J Clin Endocrinol Metab. 2004 Mar;89(3):1240-5
15001617
Carcinogenesis. 2002 Aug;23(8):1315-20
12151349
J Clin Invest. 1996 Jan 1;97(1):14-21
8550826
Endocr Relat Cancer. 2005 Dec;12(4):1071-82
16322344
J Natl Cancer Inst. 2000 Jul 19;92(14):1151-8
10904088
Neurology. 2004 Jan 27;62(2):301-3
14745075
Br J Cancer. 2004 Jan 12;90(1):153-9
14710223
J Clin Invest. 2002 Apr;109(7):973-81
11927624
Clin Endocrinol (Oxf). 2001 Jan;54(1):81-7
11167930
Atherosclerosis. 2005 Apr;179(2):369-73
15777555
Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1096-101
15894658
Clin Endocrinol (Oxf). 1989 Oct;31(4):499-509
2627750
Nat Genet. 2004 Apr;36(4):388-93
15052270
J Steroid Biochem Mol Biol. 1999 Sep-Oct;70(4-6):115-21
10622399
J Clin Endocrinol Metab. 2004 Feb;89(2):917-24
14764814
Bone. 2004 Sep;35(3):682-8
15336604
J Bone Miner Res. 1998 Jul;13(7):1167-74
9661081
J Natl Cancer Inst. 2004 Jun 16;96(12):936-45
15199113
J Clin Endocrinol Metab. 2005 Mar;90(3):1550-6
15613437
J Clin Endocrinol Metab. 2004 Jul;89(7):3261-9
15240601
J Bone Miner Res. 2005 Feb;20(2):232-9
15647817
Cell. 2005 Sep 9;122(5):751-62
16143106
Breast Cancer Res Treat. 1999 Mar;54(2):101-7
10424400
J Clin Endocrinol Metab. 2005 Apr;90(4):2198-204
15634719